Emprego da Lâmina de Imunofluorescência na ... - NewsLab

11. Castanheira M et al. Characterization of mobile elements carrying metallo-β-lactamase (MBL) genes blaimp-1, blaimp-16, blaspm-1,
blavim-2 from Latin American Medical Centers: Report from the Sentry Antimicrobial Surveillance Program. 43rd Annual Interscience
Conference on Antimicrobial Agents and Chemotherapy [c2-2023], 153.2003.
12. Castanheira M et al. Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.
Antimicrob Agents Chemother, 48(12): 4654-61, 2004.
13. Chu YM et al. A novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998.
Antimicrob Agents Chemother. 45: 710-714, 2001.
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing-Table M100-S16.
Wayne, PA, USA, 2006.
15. Cornaglia G et al. Appearance of IMP-1 metallo-b-lactamase in Europe. Lancet, 353: 899-900, 1999.
16. Crowder MV et al. Overexpression purification, and characterization of the cloned metallo-β-lactamase L1 from Stenotrophomonas
maltophilia. Antimicrob Agents Chemother. 42: 921-926, 1998.
17. Da Silva GJ et al. Molecular characterization of blaimp-5 a new integron-borne metallo-β-lactamase gene from an Acinetobacter
boumannii nosocomial isolate in Portugal. Microbiol Lett. 215: 33-39, 2002.
18. Doucquier JD et al. IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas aeruginosa putida clinical isolate.
Antimicrob Agents Chemother. 47: 1522-1528, 2003.
19. Gales AC et al. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing
SPM metallo-β-lactamase. Antimicrob Agents Chemother. 52: 699-702, 2003.
20. Gibb AP et al. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaimp allele, blaimp-7. Antimicrob
Agents Chemother. 46: 255-258, 2002.
21. Iyobe S et al. Detection of a variant metallo-β-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and a
Alcaligenes xylosoxidans strains. Antimicrob Agents Chemother. 46: 2014-2016, 2002.
22. Jacoby GA, Munoz-Price LS. The New β-lactamases. The New England Journal of Medicine. 352: 380-391, 2005.
23. Jacoby GA. Minireview: β-lactamase nomenclature. Antimicrobial Agents and Chemotherapy. 50: 1123 – 1129, 2006.
24. Kim IS, Lee NY, Ki CS, Oh WS, Peck KR, Song JH. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular
typing of metallo-β-lactamase producers in a Korean hospital. Microbial Drug Resistance. 11: 355-359, 2005.
25. Koneman EW et al. Diagnóstico Microbiológico: texto e atlas colorido. 5. ed. Rio de Janeiro: Medsi, 2001.
26. Kiska DL, Gilligan PH. Pseudomonas. In: Murray, P. R. et al. Manual of Clinical Microbiology. 8 ed. Washington: ASM press, 2003.
1212p.
27. Lauretti L. et al. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas
aeruginosa clinical isolate. Antimicrob Agents Chemother, 43(7): 1584-90, 1999.
28. Lee K et al. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates
from Korea. Antimicrob Agents Chemother, 49(11): 4485-91, 2005.
29. Linden PK, Kusne S, Coley K, Fontes P, Kramerd J, Paterson D. Use of parenteral colistin for the treatment of serious infection due to
antimicrobial – resistant Pseudomonas aeruginosa. Clinical Infect Dis., 37: e154 – e160, 2003.
30. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother, 47(3): 247-50, 2001.
31. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing integron-borne
metallo-β-lactamase (VIM-2) in the United States. Antimicrobial Agents and Chemotherapy. 49: 3538-3540, 2005.
32. Low DE, Scheld WM. Strategies for stemming the tide of antimicrobial resistence. Jama. 279: 394-395, 1998.
33. Marra AR, Pereira CA, Gales AC, Menezes LC, Cal RGR, Souza JMA, Edmond MB, Faro C, Wey SB. Bloodstream infections with metalloβ-lactamase-producing
Pseudomonas aeruginosa: epidemiology, microbiology and clinical outcomes. Antimicrobial Agents and Chemotherapy.
50: 388-390, 2006.
34. Marumo K et al. Purification and characterization of metallo-beta-lactamase from Serratia marcescens. Microbiol Immunol. 39: 27-33,
1995.
35. Mendes RE et al. First isolation of blavim-2 in Latim America: report from the Sentry Antimicrobial Surveillance Program. Antimicrobial
Agents and Chemotherapy. 48: 1433-1434, 2003.
36. Mendes RE, Castanheira M, Pignatari ACC, Gales AC. Metalo-β-lactamases. J Bras Patol Med Lab. 42: 103-113, 2006.
37. Magalhães V, Lins AK, Magalhães M. Metallo-β-lactamase producing Pseudomonas aeruginosa strains isolated in hospitals in Recife,
PE, Brasil. Brasilian Journal of Microbiology. 36: 123-125, 2005.
38. Murphy TA et al. Biochemical characterization of the acquired metallo-β-lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrobial
Agents and Chemotherapy. 47: 582-587, 2003.
39. Nordmann P. Mechanism of resistance to belactam antibiotics in P. aeruginosa. Annales Françaises d’ Anesthésie et de Réanimation,
22: 527-530, 2003.
110
NewsLab - edição 91 - 2008